| 56535-8 |
8-Dehydrocholesterol |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
8-Dehydrocholesterol [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
56535-8 |
|
|
|
|
Both |
|
|
|
0 |
8-DHC SerPl-sCnc |
|
|
|
N |
|
8-DHC; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.7 |
2.29 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 56536-6 |
Thyroglobulin Ab |
ACnc |
Ser/Plas |
Pt |
Qn |
IA |
|
ACTIVE |
Thyroglobulin Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
56536-6 |
|
IA |
|
|
Both |
|
|
|
0 |
Thyroglob Ab SerPl IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Antithyroglob; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; Hashimoto's thyroiditis; IAA; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Tg; TgAbs; Thyglobulin; Thyroglbn; Thyroglob; Tumor marker |
2.73 |
2.29 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 56537-4 |
Tissue transglutaminase Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Tissue transglutaminase IgG Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
56537-4 |
|
IA |
|
|
Both |
|
|
|
0 |
tTG IgG Ser IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Celiac disease; EIA; ELFA; ELISA; Enzyme immunoassay; Fibrin stabilizing factor; Gastro; Gastroenterology; GI; IAA; Immune globulin G; Immunoglobulin G; MEIA; Point in time; Protein-glutamine gamma glutamyltransferase; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS; TG2; tTG; UniversalLabOrders |
2.73 |
2.29 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 56538-2 |
Beta 2 glycoprotein 1 Ab |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Beta 2 glycoprotein 1 Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
COAG |
|
56538-2 |
|
IA |
|
|
Both |
|
|
|
0 |
B2 Glycoprot1 Ab Ser IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; APOH; Apolipoprotein H; Arbitrary concentration; Autoantibodies; Autoantibody; B; B2 Glycoprot1; B2 glycoprotein 1; B2GPI; B2-GPI; COAGULATION; EIA; ELFA; ELISA; Enzyme immunoassay; gG; Glycoprot; Glycoproteins; GP; Hematology; Heme; i; IAA; II; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS |
2.73 |
2.29 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 56539-0 |
Intrinsic factor Ab |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Intrinsic factor Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
56539-0 |
|
IA |
|
|
Both |
|
|
|
0 |
IF Ab Ser IA-aCnc |
|
|
|
N |
|
ABS; Absorbing intrinsic; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Fac; Fact; Hematology; Heme; IAA; IF; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS |
2.69 |
2.29 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 5654-9 |
Gallium |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Gallium [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
5654-9 |
|
|
|
|
Both |
|
|
|
0 |
Gallium Ur-mCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; GA; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 56540-8 |
Glutamate decarboxylase 65 Ab |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Glutamate decarboxylase 65 Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
SERO |
|
56540-8 |
|
IA |
|
|
Both |
|
|
|
0 |
GAD65 Ab Ser IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Autoimmune myelopathy; c707; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; GAD; GAD65; GAD-65; GADA; Glu; Glutamic acid; Glutamic acid decarboxylase-65; IAA; Insulin-Dependent Diabetes Mellitus; MEIA; Paraneoplastic neurological syndrome; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS; UniversalLabOrders |
2.73 |
2.29 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 56541-6 |
Ganglioside GD1b Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Ganglioside GD1b IgG Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
SERO |
|
56541-6 |
|
IA |
|
|
Both |
|
|
|
0 |
GD1b Gangl IgG Ser IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Disialolganglioside; Disialylganglioside; EIA; ELFA; ELISA; Enzyme immunoassay; GD1b; GD1b Gangl; IAA; Immune globulin G; Immunoglobulin G; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS |
2.73 |
2.29 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 56542-4 |
Ganglioside GD1b Ab.IgM |
ACnc |
CSF |
Pt |
Qn |
IA |
|
ACTIVE |
Ganglioside GD1b IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
SERO |
|
56542-4 |
|
IA |
|
|
Both |
|
|
|
0 |
GD1b Gangl IgM CSF IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Disialolganglioside; Disialylganglioside; EIA; ELFA; ELISA; Enzyme immunoassay; GD1b; GD1b Gangl; IAA; Immune globulin M; Immunoglobulin M; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS |
2.68 |
2.29 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 56543-2 |
Ganglioside GM2 Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Ganglioside GM2 IgG Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
SERO |
|
56543-2 |
|
IA |
|
|
Both |
|
|
|
0 |
GM2 Gangl IgG Ser IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; GM2 Gangl; IAA; Immune globulin G; Immunoglobulin G; MEIA; Monosialoganglioside; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS |
2.68 |
2.29 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 56544-0 |
Ganglioside GM2 Ab.IgM |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Ganglioside GM2 IgM Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
SERO |
|
56544-0 |
|
IA |
|
|
Both |
|
|
|
0 |
GM2 Gangl IgM Ser IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; GM2 Gangl; IAA; Immune globulin M; Immunoglobulin M; MEIA; Monosialoganglioside; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS |
2.68 |
2.29 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 56545-7 |
Ganglioside GQ1b Ab.IgM |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Ganglioside GQ1b IgM Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
SERO |
|
56545-7 |
|
IA |
|
|
Both |
|
|
|
0 |
GQ1b Gangl IgM Ser IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; GQ1b; GQ1b Gangl; IAA; Immune globulin M; Immunoglobulin M; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS; Tetrasialylganglioside |
2.73 |
2.29 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 56546-5 |
Insulin Ab |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Insulin Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
56546-5 |
|
IA |
|
|
Both |
|
|
|
0 |
Insulin Ab Ser IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; HUM; Humulin; IAA; IH7; Insul; Lente; MEIA; NPH; Point in time; QNT; Quan; Quant; Quantitative; Random; Semilente; Serology; Serum; Sliding; SR; SUDS; Ultralente |
2.73 |
2.29 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 56547-3 |
Tubular basement membrane Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Tubular basement membrane IgG Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
56547-3 |
|
IF |
|
|
Both |
|
|
|
0 |
TBM IgG Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Basem; Basemt; BM; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Point in time; Random; Serology; Serum; SmQn; SR; TBM; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.29 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 56548-1 |
U1 small nuclear ribonucleoprotein Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
U1 small nuclear ribonucleoprotein IgG Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
56548-1 |
|
IA |
|
|
Both |
|
|
|
0 |
U1 snRNP IgG Ser IA-aCnc |
|
|
|
N |
|
ABS; Aby; ANA IgG; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ribonuclear protein; RNP; Serology; Serum; snRNP; SR; SUDS; U1 RNP; U1 snRNP; U1RNP |
2.73 |
2.29 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 56549-9 |
Sjogrens syndrome-A extractable nuclear 52kD Ab |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
56549-9 |
|
IA |
|
|
Both |
|
|
|
0 |
ENA SS-A 52kD Ab Ser IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; ENA; ENA SS-A; ENA SS-A 52kD; Enzyme immunoassay; IAA; MEIA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ro; Ro AB; Serology; Serum; Sjogren; SR; SS; SSA; SS-A; SUDS |
2.73 |
2.29 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 5655-6 |
Germanium |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Germanium [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
5655-6 |
|
|
|
|
Both |
|
|
|
0 |
Germanium Ur-mCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; GE; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.42 |
1 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 56550-7 |
Purkinje cell cytoplasmic type Tr Ab |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
PCA-Tr Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
56550-7 |
|
IF |
|
|
Both |
|
|
|
0 |
PCA-Tr Ab Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Hodgkin's lymphoma; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Limbic encephalopathy; Neuro; Neurology; Paraneoplastic cerebellar degeneration; Paraneoplastic neurological syndrome; Paraneoplastic syndrome; PCD; PNS; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.29 |
|
|
|
|
|
|
|
{titer} |
|
|
Changed "Purkinje cells" in Component to the more common name, "Purkinje cell cytoplasmic". |
0 |
| 56551-5 |
Purkinje cell cytoplasmic type Tr Ab |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
PCA-Tr Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
56551-5 |
|
IF |
|
|
Both |
|
|
|
0 |
PCA-Tr Ab Titr CSF IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Hodgkin's lymphoma; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Limbic encephalopathy; Neuro; Neurology; Paraneoplastic cerebellar degeneration; Paraneoplastic neurological syndrome; Paraneoplastic syndrome; PCD; PNS; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.29 |
|
|
|
|
|
|
|
{titer} |
|
|
Changed "Purkinje cells" in Component to the more common name, "Purkinje cell cytoplasmic". |
0 |
| 56552-3 |
Dehydroepiandrosterone sulfate^baseline |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --baseline |
|
MIN |
DefinitionDescription |
|
|
mcg/dL; mcg/mL |
|
|
|
|
|
|
CHAL |
|
56552-3 |
|
|
|
|
Observation |
|
|
|
0 |
DHEA-S BS SerPl-mCnc |
|
|
|
N |
|
adrenal dysfunction; BS; CHEMISTRY.CHALLENGE TESTING; DHEA; DHEAS; DHEA-S; DHEA-SO4; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Prasterone; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SO4; SO4-2; SR; Sulf |
2.73 |
2.29 |
|
|
|
|
|
|
|
ug/dL |
|
|
|
0 |
| 56553-1 |
Albumin |
MRat |
Urine |
8H |
Qn |
Detection limit <= 20 mg/L |
|
ACTIVE |
Microalbumin [Mass/time] in 8 hour Urine |
|
MIN |
DefinitionDescription |
|
|
ug/min |
|
|
|
|
|
|
CHEM |
|
56553-1 |
|
Detection limit <= 20 mg/L |
|
|
Both |
|
|
|
0 |
Microalbumin 8h Ur-mRate |
|
|
|
N |
|
1/3 day; 8 hours; 8HR; Alb; Chemistry; DL=20 mg/L; Kidney; Left; Levo; MA; Malb; Mass rate; Micro albumin; Microalbumin; mRate; Nephrology; Protein.albumin; QNT; Quan; Quant; Quantitative; Renal; UA; UR; Urn |
2.3 |
2.29 |
|
|
|
|
|
|
|
ug/min |
|
|
|
0 |
| 56554-9 |
Porphyrins |
MRat |
Stool |
72H |
Qn |
|
|
ACTIVE |
Porphyrins [Mass/time] in 72 hour Stool |
|
MIN |
DefinitionDescription |
|
|
ug/72 H |
|
|
|
|
|
|
CHEM |
|
56554-9 |
|
|
|
|
Both |
|
|
|
0 |
Porphyrins 72h Stl-mRate |
|
|
|
N |
|
3 days; 72 hours; 72HR; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Hematology; Heme; Mass Rate; mRate; Porph; Porphyrin; QNT; Quan; Quant; Quantitative; Stl; Stool = Fecal |
2.42 |
2.29 |
|
|
|
|
|
|
|
ug/(72.h) |
|
|
|
0 |
| 56555-6 |
11-Deoxycorticosterone^baseline |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --baseline |
|
MIN |
DefinitionDescription |
|
|
ng/dL |
|
|
|
|
|
|
CHAL |
|
56555-6 |
|
|
|
|
Observation |
|
|
|
0 |
11DOC BS SerPl-mCnc |
|
|
|
N |
|
11DOC; 11-DOC; 21-Hydroxyprogesterone; BS; CHEMISTRY.CHALLENGE TESTING; DOC; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.29 |
|
|
|
|
|
|
|
ng/dL |
|
|
|
0 |
| 56556-4 |
11-Deoxycorticosterone^30M post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/dL |
|
|
|
|
|
|
CHAL |
|
56556-4 |
|
|
|
|
Observation |
|
|
|
0 |
11DOC 30M p chal SerPl-mCnc |
|
|
|
N |
|
11DOC; 11-DOC; 21-Hydroxyprogesterone; 30M p chal; After; CHEMISTRY.CHALLENGE TESTING; DOC; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.4 |
2.29 |
|
|
|
|
|
|
|
ng/dL |
|
|
|
0 |
| 56557-2 |
Renin^10M post XXX challenge |
CCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Renin [Enzymatic activity/volume] in Plasma --10 minutes post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/mL/h |
|
|
|
|
|
|
CHAL |
|
56557-2 |
|
|
|
|
Observation |
|
|
|
0 |
Renin 10M p chal Plas-cCnc |
|
|
|
N |
|
10M p chal; Active renin; After; Angiotensin forming enzyme; Angiotensinogenase; Cardio; Cardiology; Catalytic Concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Heart Disease; Kidney; Nephrology; p chal; Pl; Plasma; Plasma renin activity; Plsm; Point in time; PRA; PST; QNT; Quan; Quant; Quantitative; Random; Renal |
2.42 |
2.29 |
|
|
|
|
|
|
|
ng/mL/h |
|
|
|
0 |
